DSGN icon

Design Therapeutics
DSGN

Overview Fund Activity

91 hedge funds and large institutions have $116M invested in Design Therapeutics in 2025 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 35 increasing their positions, 33 reducing their positions, and 11 closing their positions.

Holders
91
Holders Change
-7
Holders Change %
-7.14%
% of All Funds
1.22%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
5
Increased
35
Reduced
33
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
DCM
1
Driehaus Capital Management
Illinois
$3.63M
2
WP
2
Woodline Partners
California
$2.62M
3
KCM
3
Kynam Capital Management
New Jersey
$3.47M
4
TCM
4
Tang Capital Management
California
$6M
5
AC
5
Almitas Capital
California
$5.16M

Top Sellers

1
Wellington Management Group
1
Wellington Management Group
Massachusetts
$0
2
Citadel Advisors
2
Citadel Advisors
Florida
$2.83M
3
Millennium Management
3
Millennium Management
New York
$0
4
BlackRock
4
BlackRock
New York
$8.07M
5
BNP Paribas Financial Markets
5
BNP Paribas Financial Markets
France
$12.9K
Name Market Value Shares Shares
Change 		Shares
Change %
GI
101
GAMMA Investing
California
– – -228 Closed
PS
102
Principal Securities
Iowa
– – -74 Closed
Group One Trading
103
Group One Trading
Illinois
– – – –
CAL
104
Capital Advisors Ltd
Ohio
$0 12 – –
1 2 3 4
5